HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

‘Moving At e.l.f. Speed’: First-To-Mass ‘Dupe’ Beauty Specialist Powering Through Pandemic

Executive Summary

Despite so many COVID-19 uncertainties, e.l.f. Beauty has the confidence of a company that posted 6% net sales growth to $283m for the 2020 fiscal year ended on 31 March and is seeing its value proposition for "prestige-quality" cosmetics resonate even more powerfully with consumers in today’s volatile economic climate.

You may also be interested in...



Internet’s Most Buzzed-About Beauty Brands Remain Unchanged, Including MAC Cosmetics – Cosmetify

Huda Beauty beat out Estee Lauder Companies’ MAC Cosmetics as the most followed and sought-after beauty brand online in Cosmetify’s 2021 Index. Cosmetify ranks the world’s most-searched beauty brands based on Instagram metrics and Google search volume year-over-year.

TikTok Viral Videos For #Beauty Have Direct, If Short-Lived, Impact On Amazon Product Sales

Similarweb links influencer-led viral videos on TikTok to 85% month-over-month average revenue growth on Amazon for featured beauty products.

E.l.f. Priming Alicia Keys Brand, Fans For Global Launch: ‘The World Is Craving A Brand With Soul’

Coming off its seventh consecutive quarter of net sales growth, E.l.f. expects big things from Keys Soulcare, its third and loftiest brand that is building an online community ahead of initial product launches and a global debut planned for the new year.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150067

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel